CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $175,177
- in 1 filing
Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-02 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +46,093.62 | 7,692,960.81 | ||
| 2022-05-02 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +23,046.81 | 3,846,480.4 | ||
| 2022-05-02 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +23,046.81 | 3,846,480.4 | ||
| 2022-04-28 | Clarke Anthony CSO | Option exercise | +1,000 | 3,752 | ||
| 2022-04-28 | Clarke Anthony CSO | Shares withheld for taxes | −250 | $7.43 | $2K | 3,502 |
| 2022-04-28 | Clarke Anthony CSO | Option exercise · Performance Restricted Stock Unit (PRSU) | −1,000 | 1,000 | ||
| 2022-04-28 | Wan Jerry Principal Accounting Officer | Option exercise | +1,250 | 1,344 | ||
| 2022-04-28 | Wan Jerry Principal Accounting Officer | Shares withheld for taxes | −669 | $7.43 | $5K | 675 |
| 2022-04-28 | Wan Jerry Principal Accounting Officer | Option exercise · Performance Restricted Stock Unit (PRSU) | −1,250 | 1,250 | ||
| 2022-04-28 | Stewart Richard Alistair Executive Chairman | Option exercise | +5,000 | 15,626 | ||
| 2022-04-28 | Stewart Richard Alistair Executive Chairman | Shares withheld for taxes | −2,250 | $7.43 | $17K | 13,376 |
| 2022-04-28 | Stewart Richard Alistair Executive Chairman | Option exercise · Performance Restricted Stock Unit (PRSU) | −5,000 | 5,000 | ||
| 2022-04-28 | JACOBS CINDY President & CMO | Option exercise | +2,500 | 2,723 | ||
| 2022-04-28 | JACOBS CINDY President & CMO | Shares withheld for taxes | −609 | $7.43 | $5K | 2,114 |
| 2022-04-28 | JACOBS CINDY President & CMO | Option exercise · Performance Restricted Stock Unit (PRSU) | −2,500 | 2,500 | ||
| 2022-04-28 | Bencich John CEO | Option exercise | +7,500 | 13,688 | ||
| 2022-04-28 | Bencich John CEO | Shares withheld for taxes | −1,827 | $7.43 | $14K | 11,861 |
| 2022-04-28 | Bencich John CEO | Option exercise · Performance Restricted Stock Unit (PRSU) | −7,500 | 7,500 | ||
| 2022-04-01 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +0 | |||
| 2022-04-01 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +0 |
Page 10 of 36 · 715 trades